Lonza Group

Lonza Group EBIT

The EBIT of Lonza Group (LONN.SW) as of Nov 16, 2026 is 1.24 B CHF. In the previous year, EBIT was 1.09 B CHF — a change of 13.46% (higher).

EBIT

1.24 BCHF

YoY

13.46%

Last updated:

In 2025, Lonza Group's EBIT was 1.24 B CHF, a 13.46% increase from the 1.09 B CHF EBIT recorded in the previous year.

The Lonza Group EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2023
854.00 M CHF
Jan 1, 2024
1.09 B CHF
Jan 1, 2025
1.24 B CHF
Jan 1, 2026 (e)
1.61 B CHF
Jan 1, 2027 (e)
1.89 B CHF
Jan 1, 2028 (e)
2.26 B CHF
Jan 1, 2029 (e)
2.54 B CHF
Jan 1, 2030 (e)
2.94 B CHF
The Lonza Group EBIT history
YEAREBITYoY
est2.94 BCHF+15.85%
est2.54 BCHF+12.48%
est2.26 BCHF+19.16%
est1.89 BCHF+17.76%
est1.61 BCHF+29.80%
1.24 BCHF+13.46%
1.09 BCHF+27.87%
854.00 MCHF-36.69%
1.35 BCHF+64.71%
819.00 MCHF-12.59%
937.00 MCHF+10.63%
847.00 MCHF-10.47%
946.00 MCHF+37.50%
688.00 MCHF+26.01%
546.00 MCHF+8.12%
505.00 MCHF+10.99%
455.00 MCHF+7.82%
422.00 MCHF+11.05%
380.00 MCHF+73.52%
219.00 MCHF-22.61%
283.00 MCHF+15.98%
244.00 MCHF-31.07%
354.00 MCHF+0.57%
352.00 MCHF+38.58%
254.00 MCHF—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lonza Group Revenue

Lonza Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
6.72 B CHF
854.00 M CHF
654.00 M CHF
Jan 1, 2024
5.48 B CHF
1.09 B CHF
636.00 M CHF
Jan 1, 2025
6.53 B CHF
1.24 B CHF
949.00 M CHF
Jan 1, 2026 (e)
7.12 B CHF
1.61 B CHF
1.29 B CHF
Jan 1, 2027 (e)
7.96 B CHF
1.89 B CHF
1.55 B CHF
Jan 1, 2028 (e)
8.95 B CHF
2.26 B CHF
1.84 B CHF
Jan 1, 2029 (e)
10.07 B CHF
2.54 B CHF
2.12 B CHF
Jan 1, 2030 (e)
11.10 B CHF
2.94 B CHF
2.48 B CHF

Lonza Group Margins

Lonza Group stock margins

The Lonza Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lonza Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lonza Group.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
27.04 %
12.71 %
9.74 %
Jan 1, 2024
35.99 %
19.93 %
11.61 %
Jan 1, 2025
35.35 %
18.97 %
14.53 %
Jan 1, 2026 (e)
35.35 %
22.60 %
18.19 %
Jan 1, 2027 (e)
35.35 %
23.78 %
19.50 %
Jan 1, 2028 (e)
35.35 %
25.23 %
20.56 %
Jan 1, 2029 (e)
35.35 %
25.22 %
21.09 %
Jan 1, 2030 (e)
35.35 %
26.49 %
22.33 %

Lonza Group Stock analysis

What does Lonza Group do? The Lonza Group AG is a global company based in Basel, Switzerland. It was founded in 1897 and has since had a long history of operational excellence and innovation. Lonza is a leading provider of customized chemical and biotechnological solutions and services for customers in the health, agrochemical, life science, and other sectors. Lonza's business model is based on providing customized, customer-oriented solutions for complex chemical and biological challenges. The company focuses on three main divisions: Pharma & Biotech, Consumer Health, and Specialty Ingredients. Within these divisions, Lonza offers a variety of products, services, and solutions tailored to meet the specific needs of its customers. In the Pharma & Biotech division, Lonza offers a wide range of products and services for the pharmaceutical and biotechnology industries. The company is a global leader in active ingredients for the pharmaceutical industry and also provides custom process development and manufacturing services for biopharmaceuticals and small molecules. In the Consumer Health division, Lonza develops and produces a variety of dietary supplements, cosmetic products, and household products for its customers. The company is a recognized expert in the formulation and production of high-quality dietary supplements and has also established a strong position in the production of natural cosmetic products in recent years. Lonza's Specialty Ingredients division offers a wide range of chemical and biotechnological products and services for the life science and specialty chemical industries. This includes products and services such as microbial control, material protection, custom development services, and others. Lonza is a leading manufacturer and supplier of dietary supplements, pharmaceutical active ingredients, agrochemicals, cosmetic ingredients, and other chemical and biotechnological products. The company has extensive expertise in process development and optimization, as well as in the manufacturing of products for various industries. One of Lonza's key products is the active ingredient Mipomersen, which is used in the treatment of familial hypercholesterolemia. Lonza is also a major provider of dietary supplements, particularly vitamins, minerals, omega-3 fatty acids, and other nutrients that can promote and support human health. Another important product of Lonza is the biosimilar component recombinant human insulin, which is used in the treatment of diabetes. Overall, Lonza is an innovative and leading company in the field of chemistry and biotechnology. With a strong focus on customer-oriented solutions and a broad portfolio of products and services, the company is well positioned to meet the growing demand for chemical and biological solutions in various industries. Lonza Group is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Lonza Group's EBIT

Lonza Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Lonza Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Lonza Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Lonza Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Lonza Group stock

EBIT of Lonza Group is 1.24 B CHF in 2025.

EBIT of Lonza Group changed from 1.09 B CHF to 1.24 B CHF, representing a 13.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Lonza Group since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CHF is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Lonza Group historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Lonza Group

All Key Metrics — Lonza Group